Patents

Bard Announces Patent Infringement Verdict against W. L. Gore & Associates

Published in Surgery Litigation and Law Weekly, December 28th, 2007

C. R. Bard, Inc. (NYSE: BCR) announced that a U.S. District Court jury in Arizona found that certain of W. L. Gore & Associates Inc.'s ePTFE vascular grafts and stent-grafts infringe Bard patent number 6,436,135. The jury upheld the validity of the patent and awarded $185 million in past damages. The jury also found that Gore willfully infringed the patent.

In a second phase of the trial, the court is currently assessing Gore's assertion that the patent is unenforceable due to inequitable conduct.

Bard expects that Gore will file post-trial motions with the court with respect to the jury's decision. After a judgment is entered, the case may be...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly

Source: Surgery Litigation and Law Weekly (2007-12-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry